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Introduction
Orthotopic liver transplantation (OLT) is a complex 
procedure that can be associated with massive intra-
operative haemorrhage and high requirements of blood 
products1. Intra-operative transfusion of red blood 
cells (RBC) is a major predictor of post-operative 
mortality2. It is still not clear whether RBC transfusion 
indicates a poor clinical condition and the need for 
more complex surgery, or whether it has a negative 
effect on immunomodulation3,4. In recent years, there 
has been a trend to reduce the use of blood products 
due to improved surgical techniques, anaesthetic 
management, coagulation monitoring, and decreased 
haemoglobin value triggers for RBC transfusion5,6. The 
ability to predict blood product use for the individual 
patient before surgery would optimise pre-operative 
patient management and improve co-ordination of 
resources7. However, the variables associated to 
increased blood product usage vary between centres8. 
Therefore, it is essential that each centre identifies its 
own risk factors and high-risk patients for perioperative 
transfusion before a definitive standardised model can 
be developed9,10. Our centre has been running a liver 
transplantation programme since 1995 and around 
1,100 liver transplants have been performed. The aim 
of this study was to identify which patient pre-operative 
variables best predict blood transfusion requirements 
during liver transplantation.
Materials and methods
The study was approved by the investigation 
review board (003-DEFI-NA-CES). We retrospectively 
reviewed the anaesthetics records of 543 consecutive 
patients who had undergone OLT in our centre from June 
2006 to June 2014. Re-transplantation (n=86) and liver 
transplantation for familial amyloid polyneuropathy 
(n=116) were excluded from the analysis as these were 
considered to be different entities; this left a final study 
cohort of 341 patients. Besides intra-operative RBC, 
platelets and fresh frozen plasma (FFP) consumption, 
the following pre-operative variables were collected for 
each patient: age, gender, Model for End-Stage Liver 
Disease score (MELD), primary diagnosis, international 
normalised ratio (INR), serum albumin and haemoglobin 
value. The transplanted liver was obtained from brain 
death or domino donors (livers structurally normal from 
patients with familial amyloid polyneuropathy). The 
MELD score was calculated using the standard formula 
with no adjustments for special conditions11. The liver 
transplantation team (6 hepato-biliary surgeons and 
7 anaesthesiologists) and the surgical and anaesthetic 
protocols used were the same throughout the study 
period. The Piggyback hepatectomy technique was used 
in all performed liver transplants; no intra-operative 
cell salvage is used in our centre. Decision to transfuse 
RBC was based on the Patient Blood Management 
principles12: the stage of transplant surgery, patient 
co-morbidities and physiological triggers. The number 
of RBC units was dichotomised according to our 
sample median (≤2 and >2 RBC units). Statistical 
associations between pre-operative variables and intra-
operative RBC requirements were first examined by 
univariate logistic regression. Subsequently, those 
pre-operative variables found to be significant were 
analysed through multivariate logistic regression to 
assess their independent contribution to intra-operative 
RBC transfusion. Goodness of fit for the multivariate 
model was analysed using the Hosmer and Lemeshow 
test. Linearity assumption in the logit scale for the 
continuous variables was also checked. p<0.05 was 
considered significant. Five patients were excluded from 
the multivariate analysis because of missing values. 
Statistical analysis was performed using Stata/SE11.2 for 
Windows (StataCorp LP, College Station, TX, USA)13.
Results
Patients' characteristics are listed in Table I. The 
results obtained from the univariate logistic regression 
are shown on Table II. The pre-operative variables 
found at this stage to be significantly associated with 
intra-operative RBC consumption were: MELD score, 
haemoglobin value, serum albumin, INR and primary 
diagnosis. Multivariate logistic regression of these 
variables revealed that only pre-operative MELD score, 
haemoglobin value and cholestatic liver disease were 
independently associated with intra-operative RBC 
transfusion (Table III). According to this multivariate 
analysis, for each point increase in MELD score, 
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Table I - Population characteristics (n=341).
Variable Numbers (percentages) 
or mean (median; interquartile range) 
Age (years) 51.0 (53; 46-59)
Gender
Male 231 (67.7%)
Female 110 (32.3%)
Primary diagnosis 
Alcoholic cirrhosis 155 (45.5%)
Fulminant hepatic failure 32 (9.4%)
Hepatocarcinoma 51 (14.9%)
Hepatitis B and C virus-related cirrhosis 42 (12.3%)
Cholestatic liver disease 26 (7.6%)
Miscellaneous 35 (10.3%)
MELD score 14.9 (13.5; 10.0-18.0)
RBC units (U) 3.6 (2.0; 0-5)
Intraoperative massive blood transfusion 55 (16.1)
Patients who received platelet transfusion 52 (15.2)
Patients who received fresh frozen plasma transfusion 99 (29.29)
Preoperative haemoglobin (mg dL-1) 11.8 (12.0; 9.95-13.5)
Preoperative INR 1.51 (1.3; 1.1-1.6)
Preoperative serum albumin (mg dL-1) 3.3 (3.3; 2.9-3.8)
Intraoperative massive blood transfusion (MBT) was defined as transfusion of >6 units of red blood cells 
(RBC). MELD: Model for End-Stage Liver Disease score; INR: international normalised ratio.
Table II - Univariate logistic regression of preoperative variables and >2 intraoperative 
RBC units transfusion (n=341).
Variables Odds ratio (95% CI) p 
Age (years) 1.01 (0.99-1.04) 0.14
Gender 1.41 (0.89-2.23) 0.14
MELD Score 1.09 (1.05-1.13)* 0.001
Diagnosis
Fulminant hepatic failure 2.01 (0.89-4.52) 0.09
Hepatocellular carcinoma 0.35 (0.17-0.69)* 0.003
Cholestatic liver disease 0.41 (0.17-0.99)* 0.047
Hepatitis B and C virus-related cirrhosis 1.11 (0.56-2.19) 0.77
Miscellaneous 0.69 (0.33-1.44) 0.32
Preoperative serum albumin (mg/dL-1) 0.56 (0.40-0.79)* 0.001
Preoperative haemoglobin (mg/dL-1) 0.71 (0.64-0.79)* 0.001
Preoperative INR 1.59 (1.14-2.21)* 0.006
*p<0.05. RBC: red blood cell; CI: confidence interval; MELD: Model for End-Stage Liver Disease score; 
INR: international normalised ratio.
the odds of transfusing more than two units of RBC 
increases by 7% (95% CI: 2-13%). For each g/dL-1 
increase in pre-operative haemoglobin, the odds of 
transfusing more than two units of RBC decreases by 
25% (95% CI: 14-34%). Among cholestatic liver disease 
patients, the odds of transfusing more than two units of 
RBC decreases by 64% compared to alcoholic hepatic 
cirrhosis patients (95% CI: 6-86%).
Discussion
Despite the decreasing need observed over the 
years for blood products during OLT, intra-operative 
haemorrhage remains a problem, and blood products 
are a precious and costly resource. Therefore, the 
ability to predict blood product use before surgery 
would improve co-ordination of resources by the 
transfusion department for each case and identify 
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those patients most likely to benefit from blood-saving 
strategies7.
Familial amyloid polyneuropathy is an autosomal 
hereditary systemic disease characterised by hepatic 
production of an abnormal protein that causes systemic 
amyloidosis. These patients were excluded from the 
analysis since hepatic function and structure is preserved 
and is, therefore, associated with less complex surgery 
and less intra-operative blood loss; RBC transfusion 
median at our centre is zero.
In this study, the median/mean of RBC units 
transfused intra-operatively was 2/3.6 and 104 patients 
(30.5%) did not receive any RBC. These results are in 
agreement with the decreasing use of blood products 
found in the literature14,15. In our study, median intra-
operative haemorrhage was 3,000 mL (interquartile 
range: 1,700-5,300 mL). Since a single team of 7 
anaesthesiologists carried out the transplantation 
procedure throughout the study period, the variability 
of transfusion practices at our centre for OLT was 
minimal.
In accordance with other authors14,15, we chose 
our sample median to categorise intra-operative RBC 
consumption in order to increase the power of the study. 
This cut-off (two RBC units) was lower than those used 
in other studies8,14. The analysis did not focus on the 
patients submitted to massive blood transfusion (MBT), 
since only 55 patients (16.1%) were submitted to MBT. 
The predictors of platelets and FFP transfusion were not 
studied, since in this sample requirement for such blood 
products was low.
Several studies have also identified the MELD 
score and pre-operative haemoglobin value as being 
independently associated with intra-operative RBC 
transfusion1,8,15.
Cholestatic liver disease was associated with less 
transfusional need when compared to alcoholic hepatic 
cirrhosis (our reference category, because it is the most 
prevalent primary diagnosis for OLT in our centre). 
The aetiologies of liver disease are diverse, and there 
are differences in the haemostatic profiles according to 
each one. Other studies have also found that in patients 
with cholestatic liver disease the haemostatic balance 
is generally better preserved than in patients with non-
cholestatic disease16,17. Our results are consistent with 
those studies.
In this study, intra-operative variables (intra-
operative bleeding, patient and organ survival, re-
transplantation, surgical time and cold ischemia) 
were not analysed. The aim of this study was to 
analyse pre-operative variables and predict the intra-
operative consumption of RBC in order to improve 
the management of blood component resources 
in our transfusion department. Blood is a costly 
resource. In the future, the authors hope to build 
and validate a logistic regression model that predicts 
individual RBC transfusion requirements for liver 
transplantation.
Conclusions
In our centre, pre-operative factors that were 
independently associated with intra-operative RBC 
consumption were: haemoglobin value, cholestatic 
liver disease, MELD score. Haemoglobin value was 
inversely related to RBC consumption, while MELD 
score was directly associated with the intra-operative 
administration of more than two RBC units. Cholestatic 
liver disease (relative to alcoholic hepatic cirrhosis) was 
associated with a lower requirement for intra-operative 
RBC transfusion.
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Table III - Multivariate logistic regression of preoperative variables and 
>2 intraoperative RBC units transfusion (n=336).
Variables Odds ratio (95% CI) p
MELD Score 1.07 (1.02-1.13)* 0.01
Preoperative hemoglobin (mg dL-1) 0.75 (0.66-0.86)* 0.001
Preoperative serum albumin (mg dL-1) 1.09 (0.71-1.67) 0.69
Preoperative INR 0.89 (0.58-1.38) 0.60
Diagnosis
Fulminant hepatic failure 0.68 (0.20-2.29) 0.53
Hepatocellular carcinoma 0.74 (0.34-1.59) 0.44
Cholestatic liver disease 0.36 (0.14-0.94)* 0.04
Hepatitis B and C related cirrhosis 1.13 (0.54-2.38) 0.75
Miscellaneous 0.65 (0.28-1.48) 0.30
*p<0.05 (significant values in bold). RBC: red blood cells; CI: confidence interval; MELD: Model for 
End-Stage Liver Disease score; INR: international normalised ratio.
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